Adult onset lung disease following transient disruption of fetal stretch-induced differentiation

Joseph J Hudak1, Erin Killeen, Ashok Chandran

  • 1The Brady Laboratory, Section of Neonatology, Department of Pediatrics, Stony Brook University, School of Medicine, Stony Brook, New York, 11794, USA. joseph.hudak@us.army.mil

Insights

Disrupting fetal lung development with gene therapy in rats caused progressive respiratory problems in adulthood. This highlights how early developmental changes can lead to adult-onset lung disease.

Area of Science:

  • Developmental Biology
  • Pulmonary Medicine
  • Genetics

Background:

  • Adult diseases can originate from fetal development disruptions.
  • In utero organogenesis interference can lead to long-term health issues.

Purpose of the Study:

  • To investigate respiratory function changes in aging rats after transient in utero lung growth disruption.
  • To examine the long-term effects of fetal gene interference on lung development and function.

Main Methods:

  • Fetal rats were treated in utero with an adenovirus carrying an anti-sense CFTR gene fragment.
  • Respiratory function was assessed in aging rats using lung function tests and pressure-volume curves.
  • Lung structural changes were analyzed using morphometric analysis.

Main Results:

  • In utero-treated rats showed abnormal lung function from 30 days of age, worsening with age.
  • Pulmonary function abnormalities included decreased static compliance and increased airway resistance, damping, and elastance.
  • Pressure-volume curves indicated impaired lung inflation and air trapping; these correlated with structural lung changes.

Conclusions:

  • Transient disruption of lung organogenesis via single gene interference can cause progressive changes in lung function and structure.
  • Subtle alterations in gene expression during fetal development can result in adult-onset lung disease.
  • This study provides a model for understanding fetal origins of adult respiratory diseases.

Related Concept Videos

Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
Atelectasis II: Pathophysiology01:10

Atelectasis II: Pathophysiology

Atelectasis develops when alveoli lose their air and collapse inward. Because lung tissue is naturally elastic, these air sacs shrink rather than remaining open. Collapsed alveoli are no longer ventilated, reducing their role in gas exchange. Blood flow may continue in these regions, creating a ventilation–perfusion mismatch. Clinical findings include decreased breath sounds, dullness to percussion, reduced chest expansion, and decreased tactile fremitus as sound transmission through collapsed...
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Breathing01:05

Breathing

The process of breathing, inhaling and exhaling, involves the coordinated movement of the chest wall, the lungs, and the muscles that move them. Two muscle groups with important roles in breathing are the diaphragm, located directly below the lungs, and the intercostal muscles, which lie between the ribs. When the diaphragm contracts, it moves downward, increasing the volume of the thoracic cavity and creating more room for the lungs to expand. When the intercostal muscles contract, the ribs...